H.R. 2296: FAIR Drug Pricing Act of 2019
CBO Score
$-3,490,000,000
Documentation
Date of Report
Tue September 17th, 2019
CBO Report Details
Legislation Details
116th Congress
To require reporting regarding certain drug price increases, and for other purposes.
Sponsor: Rep. Janice Schakowsky — D — IL
Requires pharmaceutical manufacturers to explain price increases for their products; instructs the Secretary of Health and Human Services to make available to the public information about discounts available to pharmacy benefit managers (PBMs); directs the Federal Trade Commission to study the pharmaceutical supply chain; expands pharmaceutical manufacturers’ reporting of their averages sales prices to Medicare; permits the HHS Secretary to disclose information about prescription drug samples to select federal agencies; prohibits pharmaceutical manufacturers from giving samples of opioids to physicians and other prescribers; and makes more information available to Medicare beneficiaries and providers about prescription drug options.
JOIN US!
Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.
Lost your Password?
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×